Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 144

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 144
---
,                                                 
 is considered a central mechanism in both neurodegenerative disease and metabolic disorders. |

| ● | Health care and wellness companies that can demonstrate evidence-based 
 anti-aging benefits are expected to drive premium valuations.          |

Nugevia Brand

The Company is launching Nugevia,
a premium line of longevity and performance supplements to enhance cellular health, mental clarity and skin vitality. The Nugevia brand
targets the growing consumer demand for science-backed wellness solutions, leveraging Jupiter’s proprietary JOTROL™ technology—a
resveratrol-based platform with a demonstrated nine-fold improvement in bioavailability.

Nugevia’s initial product
line features three core formulations, each targeting a major aspect of health and longevity:

| Product Name |     | Focus Area              |     | Target Consumer Benefit                                  |
| GLO          |     | Beauty-from-within/skin |     | Cellular skin health, collagen, hydration, UV protection |
| MND          |     | Cognitive performance   |     | Mental clarity, cognitive resilience                     |
| PWR          |     | Mitochondrial health    |     | Energy, endurance, muscle recovery                       |

Nugevia’s formulations
are built on Jupiter’s patented JOTROL™ micellar delivery platform, which has shown significantly enhanced bioavailability
and serves as the foundation for the company’s clinical-stage CNS therapies. The debut products—GLO, MND, and PWR—are
formulated to support cellular resilience through synergistic ingredient combinations, all optimized for absorption via the JOTROL™
system.

Market Positioning and Opportunities

The Nugevia brand will enter
the nutraceutical market as a premium longevity and performance supplement line, capitalizing on a global industry projected to reach
$8 trillion by 2030. Powered by JOTROL™, a patented resveratrol-based platform with nine times greater bioavailability than standard
resveratrol, Nugevia targets health-conscious consumers seeking science-backed solutions for mitochondrial health, mental clarity, and
skin vitality. Products like PWR and GLO address key market segments—dietary supplements and functional foods—driven by rising
health awareness, an aging population, and a shift toward preventive healthcare. The DTC model, launching in Q3 2025, positions Nugevia
to capture high-margin revenue in a competitive but growing market, leveraging clinical-grade credibility to stand out in a competitive
market.

| 81 |

Challenges and Competitive Landscape

The supplement market is fueled